Introduction to MDMA-assisted Therapy Research On Demand
A self-paced course that covers various topics as it relates to MDMA-Assisted Therapy research, such as PTSD, anxiety, mechanisms of action, and access issues.
Learning Objectives
At the end of this course, the participant will be able to:
- Name at least two key figures in modern clinical research with MDMA
- Articulate one reason why MDMA-assisted therapy is thought to be a good fit for treatment of PTSD
- Explain how current MDMA-assisted therapy combines non-drug psychotherapy sessions with MDMA sessions
Instructor
Chief Executive Officer, Co-Founder and Trainer Ingmar Gorman, PhD
Dr. Ingmar Gorman is a psychologist who specializes in helping people who use psychedelics and other psychoactive compounds. He received his clinical training at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University in 2017. Dr. Gorman was formerly the Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living and is now the co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. Along with Dr. Paleos, he is currently site co-principal investigator and therapist on a Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder.